BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54:1297-1306. [PMID: 21145851 DOI: 10.1016/j.jhep.2010.11.008] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Siciliano M, Parlati L, Maldarelli F, Rossi M, Ginanni Corradini S. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther 2012; 3(4): 49-61 [PMID: 22966483 DOI: 10.4292/wjgpt.v3.i4.49] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Kadry Z, Schaefer EW, Shah RA, Krok K, Du P, Bezinover D, Janicki P, Jain A, Gusani NJ, Schreibman IR, Hollenbeak CS, Riley TR. Portal Hypertension: An Underestimated Entity? Annals of Surgery 2016;263:986-91. [DOI: 10.1097/sla.0000000000001299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
3 Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-1165. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 429] [Cited by in F6Publishing: 322] [Article Influence: 53.6] [Reference Citation Analysis]
4 Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RT. Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis. Hepatology. 2019;69:729-741. [PMID: 30141205 DOI: 10.1002/hep.30230] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
5 Angeli P, Sanyal A, Moller S, Alessandria C, Gadano A, Kim R, Sarin SK, Bernardi M; International Club of Ascites. Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int 2013;33:16-23. [PMID: 22507181 DOI: 10.1111/j.1478-3231.2012.02807.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
6 Kaltenborn A, Gutcke A, Gwiasda J, Klempnauer J, Schrem H. Biliary complications following liver transplantation: Single-center experience over three decades and recent risk factors. World J Hepatol 2017; 9(3): 147-154 [PMID: 28217251 DOI: 10.4254/wjh.v9.i3.147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zaccherini G, Tufoni M, Iannone G, Caraceni P. Management of Ascites in Patients with Cirrhosis: An Update. J Clin Med 2021;10:5226. [PMID: 34830508 DOI: 10.3390/jcm10225226] [Reference Citation Analysis]
8 Wu Y, Wang S, Elsarawy AM, Chan Y, Chen C, Cheng B, Li L, Chiu C, Lee Y, Lin Y, Wee S, Pan C, Kao Y, Chen Y, Lin H, Lin L, Lin C. Prediction of the Development of Persistent Massive Ascites After Living Donor Liver Transplantation Using a Perioperative Risk Score. Transplantation 2018;102:e275-81. [DOI: 10.1097/tp.0000000000002174] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wang P, Huang G, Tam N, Wu C, Fu S, Hughes BP, Wu L, He X. Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation. Eur J Gastroenterol Hepatol 2016;28:1210-5. [PMID: 27362549 DOI: 10.1097/MEG.0000000000000690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Yacoub JH, Hsu CC, Fishbein TM, Mauro D, Moon A, He AR, Bashir MR, Burke LMB. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention. Abdom Radiol (NY) 2021;46:3528-39. [PMID: 33835223 DOI: 10.1007/s00261-021-03069-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bucher JN, Koenig M, Schoenberg MB, Crispin A, Thomas M, Angele MK, Eser-Valeri D, Gerbes AL, Werner J, Guba MO. Liver transplantation in patients with a history of migration-A German single center comparative analysis. PLoS One 2019;14:e0224116. [PMID: 31639158 DOI: 10.1371/journal.pone.0224116] [Reference Citation Analysis]
12 Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, Valla D, Lebrec D, Moreau R. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol. 2012;57:274-280. [PMID: 22521353 DOI: 10.1016/j.jhep.2012.03.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
13 Martins RM, Teodoro JS, Furtado E, Rolo AP, Palmeira CM, Tralhão JG. Recent insights into mitochondrial targeting strategies in liver transplantation. Int J Med Sci 2018;15:248-56. [PMID: 29483816 DOI: 10.7150/ijms.22891] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
14 Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology 2020;98:836-46. [PMID: 33027788 DOI: 10.1159/000502482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Chen R, Wang X, Dong J, Lin Z, Wu J, Cai Y, Shi K. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clinica Chimica Acta 2017;468:195-200. [DOI: 10.1016/j.cca.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
16 Angeli P, Gines P. Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. J Hepatol. 2012;57:1135-1140. [PMID: 22749942 DOI: 10.1016/j.jhep.2012.06.024] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
17 Maiwall R, Kumar S, Sharma MK, Wani Z, Ozukum M, Sarin SK. Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis: Hyperkalemia in decompensated cirrhosis. Journal of Gastroenterology and Hepatology 2016;31:988-94. [DOI: 10.1111/jgh.13243] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
18 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 520] [Article Influence: 165.0] [Reference Citation Analysis]
19 Brock GN, Washburn K, Marvin MR. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing. PLoS One 2019;14:e0223053. [PMID: 31581270 DOI: 10.1371/journal.pone.0223053] [Reference Citation Analysis]
20 Li C, Wen T, Yan L, Li B, Yang J, Xu M, Wang W, Wei Y. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Annals of Hepatology 2012;11:471-7. [DOI: 10.1016/s1665-2681(19)31460-7] [Cited by in Crossref: 14] [Article Influence: 1.4] [Reference Citation Analysis]
21 Preziosi ME, Monga SP. Update on the Mechanisms of Liver Regeneration. Semin Liver Dis 2017;37:141-51. [PMID: 28564722 DOI: 10.1055/s-0037-1601351] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
22 Poca M, Alvarado-Tapias E, Concepción M, Pérez-Cameo C, Cañete N, Gich I, Romero C, Casas M, Román E, Castells L, Vargas V, Carrión JA, Guarner C, Soriano G. Predictive model of mortality in patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2016;44:629-37. [PMID: 27464682 DOI: 10.1111/apt.13745] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
23 Ginanni Corradini S, Siciliano M, Parlati L, Molinaro A, Cantafora A, Poli E, Mennini G, Melandro F, Vestri AR, Merli M. Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome. Liver Int. 2014;34:e290-e301. [PMID: 24256518 DOI: 10.1111/liv.12351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Liu H, Zhang H, Wan G, Sang Y, Chang Y, Wang X, Zeng H. Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure. J Viral Hepat. 2014;21:499-507. [PMID: 24750274 DOI: 10.1111/jvh.12160] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
25 Becatti M, Mannucci A, Argento FR, Gitto S, Vizzutti F, Marra F, Taddei N, Fiorillo C, Laffi G. Super-Resolution Microscopy Reveals an Altered Fibrin Network in Cirrhosis: The Key Role of Oxidative Stress in Fibrinogen Structural Modifications. Antioxidants (Basel) 2020;9:E737. [PMID: 32806658 DOI: 10.3390/antiox9080737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Chakravorty A, White SJ, Ye IB, Cheung ZB, Kang-Wook Cho S. Effects of Underlying Liver Disease on 30-Day Outcomes After Posterior Lumbar Fusion. World Neurosurg 2019;125:e711-6. [PMID: 30735863 DOI: 10.1016/j.wneu.2019.01.160] [Reference Citation Analysis]
27 Kassela K, Karakasiliotis I, Charpantidis S, Koskinas J, Mylopoulou T, Mimidis K, Sarrazin C, Grammatikos G, Mavromara P. High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis. J Gen Virol 2017;98:1713-9. [PMID: 28708052 DOI: 10.1099/jgv.0.000851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Allegretti AS, Ortiz G, Kalim S, Wibecan J, Zhang D, Shan HY, Xu D, Chung RT, Karumanchi SA, Thadhani RI. Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury. Dig Dis Sci 2016;61:3609-20. [PMID: 27655105 DOI: 10.1007/s10620-016-4316-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
29 Godfrey EL, Malik TH, Lai JC, Mindikoglu AL, Galván NTN, Cotton RT, O'mahony CA, Goss JA, Rana A. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant 2019;19:3299-307. [DOI: 10.1111/ajt.15559] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
30 Tara A, Dominic JL, Patel JN, Garg I, Yeon J, Memon MS, Gergal Gopalkrishna Rao SR, Bugazia S, Dhandapani TPM, Kannan A, Kantamaneni K, Win M, Went TR, Yanamala VL, Mostafa JA. Mitochondrial Targeting Therapy Role in Liver Transplant Preservation Lines: Mechanism and Therapeutic Strategies. Cureus. [DOI: 10.7759/cureus.16599] [Reference Citation Analysis]
31 Cardoso FS, Bagshaw SM, Abraldes JG, Kneteman NM, Meeberg G, Fidalgo P, Kanvellas CJ. Comorbidities have a limited impact on post-transplant survival in carefully selected cirrhotic patients: a population-based cohort study. Annals of Hepatology 2015;14:505-14. [DOI: 10.1016/s1665-2681(19)31172-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Jurado-García J, Muñoz García-Borruel M, Rodríguez-Perálvarez ML, Ruíz-Cuesta P, Poyato-González A, Barrera-Baena P, Fraga-Rivas E, Costán-Rodero G, Briceño-Delgado J, Montero-Álvarez JL, de la Mata-García M. Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. PLoS One 2016;11:e0155822. [PMID: 27299728 DOI: 10.1371/journal.pone.0155822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kaltenborn A, Schrem H, Reichert B, Braun F, Emmanouilidis N, Klempnauer J, Becker T, Heits N. The Glasgow Prognostic Score and its variants predict mortality in living donor but not in deceased donor liver transplantation for hepatocellular carcinoma: A double-center validation study. Hepatol Res 2017;47:783-92. [PMID: 27598002 DOI: 10.1111/hepr.12818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Kaiser T, Kinny-Köster B, Bartels M, Berg T, Scholz M, Engelmann C, Seehofer D, Becker S, Ceglarek U, Thiery J. Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality. BMC Gastroenterol 2017;17:57. [PMID: 28427335 DOI: 10.1186/s12876-017-0614-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
35 Wendt D, Kahlert P, Canbay A, Knipp S, Thoenes M, Cremer G, Al-rashid F, Jánosi R, El-chilali K, Kamler M, El Gabry M, Marx P, Dohle DS, Tsagakis K, Benedik J, Gerken G, Rassaf T, Jakob H, Thielmann M. Impact of Liver Indicators on Clinical Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation. The Annals of Thoracic Surgery 2017;104:1357-64. [DOI: 10.1016/j.athoracsur.2017.02.075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
36 Trieu JA, Bilal M, Hmoud B. Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database. Ann Gastroenterol 2018;31:84-9. [PMID: 29333071 DOI: 10.20524/aog.2017.0217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
37 Lucidi C, Ginanni Corradini S, Abraldes JG, Merli M, Tandon P, Ferri F, Parlati L, Lattanzi B, Poli E, Di Gregorio V, Farcomeni A, Riggio O. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts. Liver Transpl 2016;22:1333-42. [DOI: 10.1002/lt.24517] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
38 Guha IN, Harris R, Berhane S, Dillon A, Coffey L, James MW, Cucchetti A, Harman DJ, Aithal GP, Elshaarawy O, Waked I, Stewart S, Johnson PJ. Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation. Clin Gastroenterol Hepatol 2019;17:2330-2338.e1. [PMID: 30716478 DOI: 10.1016/j.cgh.2019.01.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
39 Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores. Hepatobiliary Pancreat Dis Int. 2013;12:256-262. [PMID: 23742770 DOI: 10.1016/s1499-3872(13)60042-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
40 Lee WC, Wu TH, Wang YC, Cheng CH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee CS. Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease. Biomed Res Int 2017;2017:9324310. [PMID: 28884132 DOI: 10.1155/2017/9324310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
41 Torterolli F, Watanabe RK, Tabushi FI, Peixoto IL, Nassif PAN, Tefilli NL, Rocha SL, Malafaia O. BAR, SOFT AND DRI POST-HEPATIC TRANSPLANTATION: WHAT IS THE BEST FOR SURVIVAL ANALYSIS? Arq Bras Cir Dig 2021;34:e1576. [PMID: 34133523 DOI: 10.1590/0102-672020210001e1576] [Reference Citation Analysis]
42 Italian Association for the Study of the Liver (AISF). Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis 2021;53:1089-104. [PMID: 34321192 DOI: 10.1016/j.dld.2021.06.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ditisheim S, Giostra E, Burkhard PR, Goossens N, Mentha G, Hadengue A, Spahr L. A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis. BMC Gastroenterol 2011;11:134. [PMID: 22151412 DOI: 10.1186/1471-230X-11-134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Graziadei I, Zoller H, Fickert P, Schneeberger S, Finkenstedt A, Peck-Radosavljevic M, Müller H, Kohl C, Sperner-Unterweger B, Eschertzhuber S, Hofer H, Öfner D, Tilg H, Vogel W, Trauner M, Berlakovich G. Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). Wien Klin Wochenschr 2016;128:679-90. [PMID: 27590261 DOI: 10.1007/s00508-016-1046-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
45 Bouygues V, Compagnon P, Latournerie M, Bardou-Jacquet E, Camus C, Lakehal M, Meunier B, Boudjema K. MELD-based graft allocation system fails to improve liver transplantation efficacy in a single-center intent-to-treat analysis. Clin Res Hepatol Gastroenterol. 2012;36:464-472. [PMID: 22959095 DOI: 10.1016/j.clinre.2012.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
46 Ma T, Li QS, Wang Y, Wang B, Wu Z, Lv Y, Wu RQ. Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation. World J Gastroenterol 2019; 25(15): 1879-1889 [PMID: 31057301 DOI: 10.3748/wjg.v25.i15.1879] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
47 D'Avola D, Granito A, de la Torre-Aláez M, Piscaglia F. The importance of liver functional reserve in the non-surgical treatment of Hepatocellular Carcinoma. J Hepatol 2021:S0168-8278(21)02185-1. [PMID: 34793869 DOI: 10.1016/j.jhep.2021.11.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lee J, Jeong WK, Kim JH, Kim JM, Kim TY, Choi GS, Kwon CHD, Joh JW, Eom SY. Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation. Korean J Radiol 2021;22:189-97. [PMID: 33236536 DOI: 10.3348/kjr.2019.0750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Freitas M, Xavier S, Magalhães R, Magalhães J, Marinho C, Cotter J. LIRER score - a valuable tool to predict medium-long-term outcomes in hepatic cirrhosis decompensation. Scand J Gastroenterol 2020;55:1079-86. [PMID: 32715829 DOI: 10.1080/00365521.2020.1797156] [Reference Citation Analysis]
50 Hu Z, Mei S, Xiang J, Zhou J, Li Z, Zhou L, Yan S, Wang W, Zheng S. Survival rates after liver transplantation using hypertensive donor grafts: an analysis of the Scientific Registry of Transplant Recipients database. J Hepatobiliary Pancreat Sci 2017;24:441-8. [PMID: 28544515 DOI: 10.1002/jhbp.466] [Reference Citation Analysis]
51 Fox RK. When to Consider Liver Transplant During the Management of Chronic Liver Disease. Medical Clinics of North America 2014;98:153-68. [DOI: 10.1016/j.mcna.2013.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
52 Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World J Hepatol 2018; 10(2): 254-266 [PMID: 29527261 DOI: 10.4254/wjh.v10.i2.254] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
53 Mahassadi AK, Anzouan-Kacou Kissi H, Attia AK. The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study. Hepat Med 2021;13:123-34. [PMID: 34938131 DOI: 10.2147/HMER.S333980] [Reference Citation Analysis]
54 Wyssusek KH, Keys AL, Yung J, Moloney ET, Sivalingam P, Paul SK. Evaluation of perioperative predictors of acute kidney injury post orthotopic liver transplantation. Anaesth Intensive Care 2015;43:757-63. [PMID: 26603801 DOI: 10.1177/0310057X1504300614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Gastaca M, Valdivieso A, Bustamante J, Fernández JR, Ruiz P, Ventoso A, Testillano M, Palomares I, Salvador P, Prieto M, Montejo M, Suárez MJ, de Urbina JO. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort. Liver Transpl 2016;22:1391-400. [PMID: 27434676 DOI: 10.1002/lt.24514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
56 Valantine B, Sundaray N, Mishra D, Sahu S, Narayan J, Panda BN, Singh A. Predictors of early mortality among patients with acute-on-chronic liver failure. JGH Open 2021;5:686-94. [PMID: 34124387 DOI: 10.1002/jgh3.12557] [Reference Citation Analysis]
57 Nagai S, Chau LC, Schilke RE, Safwan M, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Moonka D. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes. Gastroenterology 2018;155:1451-1462.e3. [DOI: 10.1053/j.gastro.2018.07.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
58 Karapanagiotou A, Kydona C, Dimitriadis C, Papadopoulos S, Theodoridou T, Tholioti T, Fouzas G, Imvrios G, Gritsi-gerogianni N. Impact of the Model for End-Stage Liver Disease (MELD) Score on Liver Transplantation in Greece. Transplantation Proceedings 2014;46:3212-5. [DOI: 10.1016/j.transproceed.2014.10.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Golse N, Bucur PO, Ciacio O, Pittau G, Sa Cunha A, Adam R, Castaing D, Antonini T, Coilly A, Samuel D, Cherqui D, Vibert E. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation: GOLSE ET AL. Liver Transpl 2017;23:143-54. [DOI: 10.1002/lt.24671] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 15.8] [Reference Citation Analysis]
60 Stravitz RT, Reuben A, Mizrahi M, Lalazar G, Brown K, Gordon SC, Ilan Y, Sanyal A. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation. J Hepatol. 2015;63:1345-1351. [PMID: 26220750 DOI: 10.1016/j.jhep.2015.07.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
61 Kuster N, Bargnoux AS, Pageaux GP, Cristol JP. Limitations of compensated Jaffe creatinine assays in cirrhotic patients. Clin Biochem. 2012;45:320-325. [PMID: 22178107 DOI: 10.1016/j.clinbiochem.2011.11.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
62 Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. American Journal of Roentgenology 2018;210:766-74. [DOI: 10.2214/ajr.17.18725] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
63 Mohamadnejad M, Alimoghaddam K, Bagheri M, Ashrafi M, Abdollahzadeh L, Akhlaghpoor S, Bashtar M, Ghavamzadeh A, Malekzadeh R. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int. 2013;33:1490-1496. [PMID: 23763455 DOI: 10.1111/liv.12228] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
64 Schlegel A, Muller X, Dutkowski P. Machine perfusion strategies in liver transplantation. Hepatobiliary Surg Nutr 2019;8:490-501. [PMID: 31673538 DOI: 10.21037/hbsn.2019.04.04] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
65 Yoo SY, Kim GS. Changes in the allocation policy for deceased donor livers in Korea: perspectives from anesthesiologists. Anesth Pain Med (Seoul) 2021;16:68-74. [PMID: 33486941 DOI: 10.17085/apm.20035] [Reference Citation Analysis]
66 Ivanics T, Abreu P, De Martin E, Sapisochin G. Changing Trends in Liver Transplantation: Challenges and Solutions. Transplantation 2021;105:743-56. [PMID: 32910093 DOI: 10.1097/TP.0000000000003454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
67 Wagener G, Raffel B, Young AT, Minhaz M, Emond J. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score. Liver Transpl. 2013;19:534-542. [PMID: 23576469 DOI: 10.1002/lt.23634] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
68 Sirrs SM, Faghfoury H, Yoshida EM, Geberhiwot T. Barriers to transplantation in adults with inborn errors of metabolism. JIMD Rep 2013;8:139-44. [PMID: 23430530 DOI: 10.1007/8904_2012_171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
69 Goel A, Kim WR, Pyke J, Schladt DP, Kasiske BL, Snyder JJ, Lake JR, Israni AK. Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35? Transplantation 2018;102:769-74. [DOI: 10.1097/tp.0000000000002079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Hibi T, Nishida S, Sageshima J, Levi DM, Ruiz P, Roth D, Martin P, Okabayashi K, Burke GW, Ciancio G, Tzakis AG. Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C. Transpl Int 2014;27:606-16. [PMID: 24606223 DOI: 10.1111/tri.12303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
71 Tufoni M, Zaccherini G, Caraceni P, Bernardi M. Albumin: Indications in chronic liver disease. United European Gastroenterol J 2020;8:528-35. [PMID: 32213034 DOI: 10.1177/2050640620910339] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Machado AGDS, Jr. ADMF, Marroni C, Zanotelli ML, Cantisani G, Brandão ABDM. Impact of MELD score implementation on liver allocation: experience at a Brazilian center. Annals of Hepatology 2013;12:440-7. [DOI: 10.1016/s1665-2681(19)31007-5] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
73 Hu C, Wu Z, Li L. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. Int J Biol Sci. 2020;16:893-903. [PMID: 32071558 DOI: 10.7150/ijbs.39725] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
74 Györi GP, Silberhumer GR, Zehetmayer S, Kern B, Hetz H, Soliman T, Steininger R, Mühlbacher F, Berlakovich GA. Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation: DeltaMELD predicts survival after liver transplantation. Transplant International 2012;25:935-40. [DOI: 10.1111/j.1432-2277.2012.01519.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
75 Isabel Musskopf M, Pimentel Fonseca F, Gass J, Zambam de Mattos A, Alberto John J, Bandeira de Mello Brandao A. Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis. Annals of Hepatology 2012;11:915-20. [DOI: 10.1016/s1665-2681(19)31418-8] [Cited by in Crossref: 12] [Article Influence: 1.2] [Reference Citation Analysis]
76 Lladó L, Bustamante J. IV Reunión de Consenso de la Sociedad Española de Trasplante Hepático 2012. Excepciones al Model for End-stage Liver Disease en la priorización para trasplante hepático. Gastroenterología y Hepatología 2014;37:83-91. [DOI: 10.1016/j.gastrohep.2013.06.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
77 Lattanzi B, Nardelli S, Pigliacelli A, Di Cola S, Farcomeni A, D'Ambrosio D, Gioia S, Ginanni Corradini S, Lucidi C, Mennini G, Rossi M, Merli M, Riggio O. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease. Dig Liver Dis 2019;51:1508-12. [PMID: 31601536 DOI: 10.1016/j.dld.2019.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
78 Tandon P, Kumar D, Seo YS, Chang HJ, Chaulk J, Carbonneau M, Qamar H, Keough A, Mansoor N, Ma M. The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis. Am J Gastroenterol. 2013;108:1473-1479. [PMID: 23877350 DOI: 10.1038/ajg.2013.204] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
79 Moore C, Levitsky J. New models to enhance the assessment of mortality risk in low model for end-stage liver disease patients: "objectifying" the subjective. Liver Transpl 2014;20:1153-4. [PMID: 25060899 DOI: 10.1002/lt.23963] [Reference Citation Analysis]
80 Benko T, Gallinat A, Minor T, Saner FH, Sotiropoulos GC, Paul A, Hoyer DP. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers: . European Journal of Gastroenterology & Hepatology 2017;29:716-22. [DOI: 10.1097/meg.0000000000000851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Agalar C, Egeli T, Unek T, Ozbilgin M, Aysal A, Cevlik AD, Sagol O, Bacakoglu A, Ellidokuz H, Astarcioglu I. The Predictive Ability of the Glasgow Prognostic Score and Variants in Both Deceased Donor and Living Donor Liver Transplantation for Hepatocellular Cancer. Transplant Proc 2019;51:1134-8. [PMID: 31101186 DOI: 10.1016/j.transproceed.2019.02.004] [Reference Citation Analysis]
82 Koo JK, Kim JH, Choi YJ, Lee CI, Yang JH, Yoon HY, Choi HJ, Ko SY, Choe WH, Kwon SY, Lee CH. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis: Value of Refit Model for End-stage Liver Disease. J Gastroenterol Hepatol 2013;28:1209-16. [DOI: 10.1111/jgh.12156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
83 Kalid N, Zaidan AA, Zaidan BB, Salman OH, Hashim M, Muzammil H. Based Real Time Remote Health Monitoring Systems: A Review on Patients Prioritization and Related "Big Data" Using Body Sensors information and Communication Technology. J Med Syst 2017;42:30. [PMID: 29288419 DOI: 10.1007/s10916-017-0883-4] [Cited by in Crossref: 93] [Cited by in F6Publishing: 43] [Article Influence: 18.6] [Reference Citation Analysis]
84 Neuberger J. Rationing life-saving resources - how should allocation policies be assessed in solid organ transplantation: Criteria for organ allocation. Transplant International 2012;25:3-6. [DOI: 10.1111/j.1432-2277.2011.01327.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
85 Zhang X, Ying Y, Zhou P, Liu X, Li R, Tao Y, Dong M, Zhu B, Qi X, Wang Q, Zhang X, Wu J, Zheng J, Zhao W, Zhang W, Wang Z, Zhang J, Huang Y. A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation. Dig Dis Sci 2021;66:284-95. [PMID: 32140946 DOI: 10.1007/s10620-020-06149-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]